论文部分内容阅读
Background: To evaluate the efficacy of two botulinum toxin A injection patterns with or without the medial lower eyelid (MLE) in treating benign essential blepharospasm (BEB) and influencing lacrimal drainage.Design: Prospective, randomized clinical trial.